Company Profiles

driven by the PitchBook Platform

Apexigen

Description

Developer of bio-pharmaceutical products for antibody product candidates. The company provides a therapeutics platform based on rabbit-derived monoclonal antibodies, as a means of targeting previously unreachable disease mechanisms. It has also developed a product pipeline of several antibody programs, with applications for oncology, inflammatory disease and ophthalmology.

2010

Founded

PRIVATE

Status

1-10

Employees

Series B

Latest Deal Type

$15M

Latest Deal Amount

$35M

Total Amount Raised

Description

Developer of bio-pharmaceutical products for antibody product candidates. The company provides a therapeutics platform based on rabbit-derived monoclonal antibodies, as a means of targeting previously unreachable disease mechanisms. It has also developed a product pipeline of several antibody programs, with applications for oncology, inflammatory disease and ophthalmology.

Website:

www.apexigen.com

Formerly Known As

Apex Biotherapeutics

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals

Primary Office

75 Shoreway Road Suite C San Carlos, CA 94070United States +1 (650) 931-6236
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Apexigen's full profile, request a free trial.

Apexigen Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Apexigen Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Apexigen Investors (7)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Amkey VenturesVenture CapitalMinority000 0000000 0000
CDIB Capital GroupVenture CapitalMinority000 0000000 0000
Kenson VenturesVenture CapitalMinority000 0000000 0000
Sycamore VenturesPE/BuyoutMinority000 0000000 0000
Themes Investment PartnersPE/BuyoutMinority000 0000000 0000
Amkey Ventures Venture Capital
CDIB Capital Group Venture Capital
Kenson Ventures Venture Capital
Sycamore Ventures PE/Buyout
Themes Investment Partners PE/Buyout

Apexigen Executive Team (5)

NameTitleBoard
Seat
Contact
Info
Xiaodong YangChief Executive Officer, President and Board Member
Yongke Zhang Ph.DSenior Director of Research and Collaborations
Amy WongVice President, Finance
Mark NevinsVice President of Business Development
Ovid Trifan MDVice President of Clinical Development
Xiaodong Yang Chief Executive Officer, President and Board Member
Yongke Zhang Ph.D Senior Director of Research and Collaborations
Amy Wong Vice President, Finance
Mark Nevins Vice President of Business Development
Ovid Trifan MD Vice President of Clinical Development

Apexigen Board Members (4)

NameRepresentingRoleSinceContact
Info
George Lee Ph.DAmkey VenturesCo-Founder & Managing Director000 0000
Kenneth Fong Ph.DKenson VenturesFounder & Chairman000 0000
William RutterSelfBoard Member000 0000
Xiaodong YangApexigenChief Executive Officer, President and Board Member000 0000
George Lee Ph.D Co-Founder & Managing Director Amkey Ventures
Kenneth Fong Ph.D Founder & Chairman Kenson Ventures
William Rutter Board Member Self
Xiaodong Yang Chief Executive Officer, President and Board Member Apexigen
Request full access to PitchBook